Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Neurology|July 17, 2025
Frequency, Risk Factors, and Outcomes of Strokes in Patients With Primary Glioma After Cranial Radiation TherapyDylan Ryan, Megumi Sugita, Gloria Broadwater, et al.Cancer Causes & Control : CCC|September 15, 2010
Association between body mass index and mortality in patients with glioblastoma mutliformeLee W Jones, Francis Ali-Osman, Eric Lipp, et al.Epilepsy & Behavior Case Reports|November 1, 2018
Adjunctive perampanel for glioma-associated epilepsyAnastasie M Dunn-Pirio, Sarah Woodring, Eric Lipp, et al.Neuro-Oncology Practice|November 17, 2022
Patterns of care in adult histone mutant gliomas: Results of an international surveyAlexander Yuile, Mustafa Khasraw, Justin T Low, et al.The Oncologist|April 19, 2018
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant GliomaMary Lou Affronti, Jennifer Gamboa Jackman, Frances McSherry, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2022
Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trialKatherine B Peters, Mary L Affronti, Sarah Woodring, et al.Oncotarget|October 22, 2013
The genetic landscape of anaplastic astrocytomaPatrick J Killela, Christopher J Pirozzi, Zachary J Reitman, et al.Journal of Neuro-Oncology|January 8, 2015
Prognostic marker analysis in pediatric intracranial ependymomasRoger E McLendon, Eric Lipp, Diane Satterfield, et al.The Lancet. Child & Adolescent Health|April 2, 2023
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trialEric M Thompson, Daniel Landi, Michael C Brown, et al.Oncotarget|April 12, 2014
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomasPatrick J Killela, Christopher J Pirozzi, Patrick Healy, et al.Pageof 2